Syntone Ventures LLC 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-04 8:55 pm Purchase |
2021-02-03 | 13D | Outlook Therapeutics, Inc. OTLK |
Syntone Ventures LLC | 991,152 11.700% |
191,152 (+23.89%) |
Filing |
| 2020-06-12 4:17 pm Purchase |
2020-06-02 | 13D | Outlook Therapeutics, Inc. OTLK |
Syntone Ventures LLC | 800,000 14.900% |
800,000 (New Position) |
Filing |